Medium-chain triglycerides modulate ileitis induced by trinitrobenzene sulfonic acid

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 12, 1999, Pages 1166-1172

  Tsujikawa, Tomoyuki ^a   Ohta, Noriyasu ^b   Nakamura, Tsuyoshi ^b   Satoh, Jin ^a   Uda, Katsuhiro ^a   Ihara, Takashi ^a   Okamoto, Toshihiko ^a   Araki, Yoshio ^a   Andoh, Akira ^a   Sasaki, Masaya ^a   Fujiyama, Yoshihide ^a   Bamba, Tadao ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

Ileitis; Medium chain triglycerides; Trinitrobenzene sulfonic acid

Indexed keywords

LEUKOTRIENE B4; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; SIALIC ACID; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FAT INTAKE; GRANULOMA; HISTOPATHOLOGY; ILEITIS; INTESTINE ULCER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR;

EID: 0033427731     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.02024.x     Document Type: Article

References (25)

1. 1 Allison MC, Poulter LW. Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of inflammatory bowel disease. Clin. Exp. Immunol. 1991; 85: 504-9.
2. 2 Brandtzaeg P, Halstensen TS, Kett K et al. Immunology and immunopathology of human gut mucosa: Humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989; 97: 1562-84.
3. 3 Qiao L, Schurmann G, Meuer SC, Autschbach F. Activation of lamina propria T lymphocytes in Crohn's disease. Adv. Exp. Med. Biol. 1995; 371B: 1287-91.
4. 4 Stronkhorst A, Radema S, Yong SL et al. CD4 antibody treatment in patients with active Crohn's disease: A phase I dose finding study. Gut 1995; 40: 320-7.
5. 5 Sawada K, Oshitani K, Fukui S et al. Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J. Gastroenterol. 1995; 30: 322-9.
6. 6 Morris GP, Beck PL, Herridge MS, DepewWT, Szewczuk MR, Wallace JL. Happen-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
7. 7 Penza E, Franceshi S, La Vecchia S. Dietary factors in the aetiology of inflammatory bowel disease. Ital. J. Gastroenterol. 1987; 19: 205-9.
8. 8 Martini GA, Brandes JW. Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin. Wocheschr. 1976; 54: 367-71.
9. 9 Persson PG, Ahlbom A, Heller G. Crohn's disease and ulcerative colitis. A review of dietary studies with emphasis on methodologic aspects. Scand. J. Gastroenterol, 1987; 22: 385-9.
10. 10 Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiological analysis of Crohn's disease in Japan: Increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn's disease in Japan. Am. J. Clin. Nutr. 1996; 63: 741-5.
11. 11 Vilaseca J, Salas A, Guarner F, Rodriguez R, Martìnez M, Malagelada JR. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 1990; 31: 539-44.
12. 12 Luk GD, Baylin SB. Polyamines and intestinal growth: Increased polyamine biosynthesis after jejunectomy. Am. J. Physiol. 1983; 245: G656-60.
13. 13 Ricci G, D'Ambrosi A, Resca D, Masotti M, Alvisi V. Comparison of serum total sialic acid, C-reactive protein, alpha 1-acid glycoprotein and beta 2-microglobulin in patients with non-malignant bowel disease. Biomed. Pharmacother. 1995; 5: 259-62.
14. 14 Lipkin M, Sherlock P, Bell B. Cell proliferation kinetics in the gastrointestinal tract of man. II. Cell renewal in stomach, ileum, colon, and rectum. Gastroenterology 1963; 45: 721-9.
15. 15 Cheeseman CI. Expression of amino acid and peptide transport system in rat small intestine. Am. J. Physiol. 1986; 251: G636-41.
16. 16 Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A. Supplementary enteral nutrition maintains remission in pediatric Crohn's disease. Gut 1996; 38: 543-8.
17. 17 Koga H, Iida M, Aoyagi K, Matsui T, Fujishima M. Long-term efficacy of low residue diet for the maintenance of remission in patients with Crohn's disease. Jpn. J. Gastroenterol. 1993; 90: 2882-8.
18. 18 Polk DB, Hattner JAT, Kerner JA. Improvement in growth and disease activity after intermittent injection of a defined formula diet in children with Crohn's disease. JPEN 1992; 16: 499-504.
19. 19 Miura S, Imaeda H, Shiozaki H et al. Increased proliferative response of lymphocytes from lymph during long chain fatty acid absorption. Immunology 1993; 7: 142-6.
20. 20 Hirokawa M, Miura S, Yoshida H et al. Enhanced synthesis and release of vasoactive substance during absorption of fatty acid micelles in intestinal epithelial cells. Gastroenterology 1997; 112; A879.
21. 21 Greenberger NJ. Metabolic and clinical studies of medium chain triglycerides in subjects with inflammatory bowel disease. In: Senior JR, ed. Medium Chain Triglycerides. Philadelphia: University of Pennsylvania Press. 1968; 145-54.
22. 22 Tasman-Jones C. Medium chain triglycerides in the therapy of small bowel Crohn's disease. NZ Med. J. 1971; 73: 214-15.
23. 23 Tsujikawa T, Bamba T, Hososa S. The trophic effect of epidermal growth factor on morphological changes and polyamine metabolism in the small intestine of rats. J. Gastroenterol. 1990; 25: 328-34.
24. 24 Marcuard SP, Silverman JF, Finley JL, Seidel ER. Ornithine decarboxylase activity during gastric ulcer healing in dogs. Dig. Dis. Sci. 1992; 37: 1015-19.
25. 25 Jenkins AP, Thompson RP. Does the fatty acid profile of dietary fat influence its trophic effect on the small intestinal mucosa? Gut 1993; 34: 358.